Surmodics reported $177.2M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Align Technology ALGN:US $ 5395.57M 325.79M
Anika Therapeutics ANIK:US $ 363.13M 0.88M
Arrowhead Research ARWR:US $ 734.93M 21.87M
Baxter International BAX:US $ 19682M 216M
Bioscrip BIOS:US $ 2718.76M 78.29M
Cryolife CRY:US $ 810.5M 15.66M
Edap Tms EDAP:US $ 74.62M 21.32M
Edwards Lifesciences EW:US $ 7662.1M 448.4M
Genmark Diagnostics GNMK:US $ 223.53M 8.94M
Haemonetics HAE:US $ 1794.19M 25.74M
Heron Therapeutics HRTX:US $ 404.25M 93.32M
Merit Medical Systems MMSI:US $ 1642.39M 9.33M
Mesa Laboratories MLAB:US $ 612.49M 11.02M
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Oxford Immunotec Global OXFD:US $ 210.5M 3.89M
Providence Service PRSC:US $ 1576.2M 44.42M
Stryker SYK:US $ 33698M 243M
Surmodics SRDX:US $ 177.2M 0.1M
Trinity Biotech TRIB:US $ 124.72M 11.26M